Ohio Revised Code provisions on telehealth (4731.741, 4743.09) allow Ohio-licensed physicians to prescribe GLP-1 medications via telehealth without a prior in-person visit, provided the encounter meets Ohio standard-of-care requirements
References: Ren Y, Chen Y, Zheng W, Kong W, Liao Y, Zhang J, Wang M, Zeng T
As the majority of patients with T2DM are also obese, medications that exacerbate weight gain are not ideal
Using the pattern management tool shown in Table 5 helps to identify where the insulin change may need to be made
According to FDA prescribing information, nausea occurs in 1544% of patients depending on the specific agent and dose, with vomiting, diarrhea, constipation, and abdominal pain also frequently reported